ESOT2017 AWARDS

As part of the ESOT commitment to advancing education and research in Transplantation, a number of Awards are given at each ESOT Congress to abstract presenters, in recognition of their contribution. 

Our warmest congratulations to the winners of the ESOT2017 Awards, celebrated at our last Congress in Barcelona (24-27 September 2017):

ESOT YOUNG INVESTIGATOR AWARD supported by Roche

  • Fabian Halleck, Berlin, Germany
    OS092 – ACCIDENTAL TRANSMISSION OF HEPATITIS C (HCV) VIRUS FROM AN ORGAN DONOR TO FIVE TRANSPLANT RECIPIENTS: EARLY TREATMENT WITH DIRECT ACTING ANTIVIRALS SUCCESSFULLY PREVENTS CHRONIC HCV INFECTION
  • Riccardo Tamburrini, Winston-Salem, United States
    OS241 – SUCCESSFUL TRANSPLANTATION OF A HUMAN TISSUE ENGINEERED BOWEL (HTEB) IN AN ATHYMIC RAT MODEL
  • Maarten Coemans, Leuven, Belgium
    OS265 – SHORT AND LONG TERM GRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATION IN EUROPE
  • Marc Lucia, Stanford, United States
    OS285 – STRATEGY FOR ANALYSIS OF DONOR-SPECIFIC ANTIBODY REPERTOIRE: PAIRED IMMUNOGLOBULIN HEAVY AND LIGHT CHAIN ANALYSIS OF INDIVIDUAL MEMORY B CELLS
  • Jorge Malheiro, Porto, Portugal
    OS323 – EARLY ANTIBODY-MEDIATED REJECTION C4D STATUS REMAINS A MARKER OF PROGNOSIS IN HLA-INCOMPATIBLE KIDNEY TRANSPLANTATION
  • Kamlesh Patel, Birmingham, United Kingdom
    OS331 – HYPOTHERMIC MACHINE PERFUSION FOLLOWING STATIC COLD STORAGE IN DONATION AFTER CARDIAC DEATH CADAVERIC KIDNEYS: A UK POPULATION-BASED COHORT STUDY
  • Andrea Schlegel, Birmingham, United Kingdom
    OS300 – THE UK-DCD-RISK-SCORE – A NEW PROPOSAL TO DEFINE FUTILITY IN DCD LIVER TRANSPLANTATION
  • Abdul Hakeem, Cambridge, United Kingdom
    OS387 PANCREATIC ALLOGRAFT THROMBOSIS: SUGGESTION FOR A CT GRADING SYSTEM AND MANAGEMENT ALGORITHM
  • Nabil Melhem, London, United Kingdom
    OS441 – MEDICATION NON-ADHERENCE IS A LEADING CAUSE FOR RENAL GRAFT LOSS IN CHILDHOOD – A LARGE CENTRE STUDY
  • Yoshiki Wada, Sapporo, Japan
    OS431 – EVEROLIMUS SUPPRESSES IGA DEPOSITION AND RECURRENCE OF IGA NEPHROPATHY AFTER KIDNEY TRANSPLANTATION

BAC – BEST ABSTRACT CHALLENGE AWARD supported by Biotest

  • BAC001 – OUTCOME AFTER KIDNEY TRANSPLANTATION IS INDEPENDENTLY PREDICTED BY DONOR RECIPIENT MATCHING BASED ON INDIRECTLY RECOGNIZABLE HLA EPITOPES
    Presented by Oliver Staeck, Berlin, Germany
  • BAC004 – NORMOTHERMIC MACHINE PERFUSION VS STATIC COLD STORAGE IN LIVER TRANSPLANTATION: OUTCOMES FROM A RANDOMISED CONTROLLED TRIAL
    Presented by David Nasralla, Oxford, United Kingdom
  • BAC005 – VALIDATION OF THE HOMEOSTATIC MODEL ASSESSMENT (HOMA) OF BETA CELL FUNCTION IN PANCREAS TRANSPLANTATION
    Presented by James Barnes, Oxford, United Kingdom
  • BAC006 – BORTEZOMIB IN LATE ANTIBODY-MEDIATED KIDNEY TRANSPLANT REJECTION – A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL (BORTEJECT STUDY)
    Presented by Farsad Eskandary, Vienna, Austria
  • BAC008 – MISSING-SELF TRIGGERS NK MEDIATED MICROVASCULAR INJURIES AND CHRONIC REJECTION OF ALLOGENIC KIDNEY TRANSPLANTS
    Presented by Alice Koenig, Lyon, France
  • BAC009 – SPECIFIC GENE EXPRESSION SIGNATURE OF COMPLEMENT-ACTIVATING DONOR SPECIFIC ANTI-HLA ANTIBODY-MEDIATED REJECTION IN KIDNEY ALLOGRAFTS
    Presented by Carmen Lefaucheur, Paris, France

STRONGERTOGETHER AWARD supported by European National Transplant Societies
ERASMUS MEDICAL CENTERRotterdam, The Netherlands

STRONGERTOGETHER PRO AWARD
PARIS TRANSLATIONAL RESEARCH CENTRE FOR ORGAN TRANSPLANTATIONParis, France

BE – BEST #ESOTtrustedPartner AWARD

  • Maria Irene Bellini, London, United Kingdom
  • Edoardo Melilli, Barcelona, Spain

EUROLIVER AWARDS supported by Euroliver Foundation

  • OS023 THE INTRODUCTION OF A DCD DONOR ASSESSMENT PATHWAY HAS INCREASED DCD REFERRALS, PROCEEDING DCD DONORS AND DECREASED THE RATE OF UNNECESSARY FAMILY APPROACHES FOR CONSENT
    Presented by Andrew Broderick, Bristol, United Kingdom
  • OS290 IMPACT OF ‘RESCUE ALLOCATED’ LIVERS ON OUTCOMES AFTER LIVER TRANSPLANTATION: A PROPENSITY SCORE MATCHING ANALYSIS
    Presented by Mara Disabato, Paris, France